González-Cao, María; Puertolas, Teresa; Riveiro, Mar; Muñoz-Couselo, Eva; Ortiz, Carolina; Paredes, Roger; Podzamczer, Daniel; Manzano, José-Luis; Molto, José; Revollo, Boris; Carrera, Cristina; Mateu, Lourdes; Fancelli, Sara; Espinosa, Enrique; Clotet, Bonaventura; Martínez-Picado, Javier; Cerezuela, Pablo; Soria, Ainara; Márquez, Ivan; Mandala, Mario; Berrocal, Alfonso
(BMJ PUBLISHING GROUP, 2021)
Cancer immunotherapy based on the use of antibodies targeting the so-called checkpoint inhibitors, such as programmed cell death-1 receptor, its ligand, or CTLA-4, has shown durable clinical benefit and survival improvement ...